What drugs should not be taken while taking Serpatinib?
Drugs that should be banned when taking serpatinib mainly include the following categories:
Proton pump inhibitors: such as dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole sodium, and rabeprazole. When these drugs are used concurrently with serpatinib, drug-drug interactions may occur, affecting the efficacy of serpatinib or increasing patient risks.
H2 blockers: such as famotidine, nizatidine, and cimetidine. These drugs may also interact with serpatinib, resulting in increased or decreased efficacy, or even adverse reactions.
Antacids containing aluminum, magnesium, calcium, simethicone, or buffered drugs: These drugs may react chemically with serpatinib, affecting the absorption and distribution of the drug, thereby reducing the therapeutic effect of serpatinib.
In addition to the above-mentioned explicitly prohibited drugs, there are other drugs that require special attention when used concurrently with serpatinib:
Strong and moderateCYP3A inducers: These drugs may reduce the plasma concentration of serpatinib, thus affecting its efficacy. Therefore, the dose of serpatinib may need to be adjusted or concomitant use avoided when using this class of drugs.
In addition, the use of serpatinib also requires special caution for certain groups of people, such as patients with hepatic insufficiency, pregnant women, and lactating women. These people should consult a professional doctor and follow the doctor's advice before using serpatinib.
At the same time, patients should read the drug instructions carefully before taking the drug to understand the contraindications, adverse reactions, interactions and other information of the drug. Use medication under the guidance of a doctor, and do not blindly adjust the dosage or change medications on your own. Through scientific and rational use of medication, discomfort symptoms can be minimized and the therapeutic effect and safety of the medication can be ensured.
References:
https://www.medicalnewstoday.com/articles/drugs-retevmo-interactions
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)